The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis

Published:2011-11-20 Issue:12 Volume:17 Page:1652-1656
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Cudkowicz Merit,Bozik Michael E,Ingersoll Evan W,Miller Robert,Mitsumoto Hiroshi,Shefner Jeremy,Moore Dan H,Schoenfeld David,Mather James L,Archibald Donald,Sullivan Mary,Amburgey Craig,Moritz Juliet,Gribkoff Valentin K

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2579.pdf

Reference39 articles.

1. Rowland, L.P. & Shneider, N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688–1700 (2001).

2. Wijesekera, L.C. & Leigh, P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 4, 3 (2009).

3. Vucic, S. & Kiernan, M.C. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr. Mol. Med. 9, 255–272 (2009).

4. Hervias, I., Beal, M.F. & Manfredi, G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve 33, 598–608 (2006).

5. Manfredi, G. & Xu, Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5, 77–87 (2005).

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New opportunities for antioxidants in amelioration of neurodegenerative diseases;Mechanisms of Ageing and Development;2024-10

2. Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders;Current Topics in Medicinal Chemistry;2024-09

3. Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis;Reviews in the Neurosciences;2024-02-22

4. Amyotrophic lateral sclerosis: exploring pathophysiology in the context of treatment;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-11-24

5. Harmonized standard operating procedures for administering the ALS functional rating scale-revised;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-09-20